ArticleStem cell research & therapy2023

Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19.

Tian-Tian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.